I have excellent content from Goldman-Cecil (diagnosis, clinical manifestations, treatment) and Robbins (pathology). The file content also included a long treatment section. I have enough comprehensive information to produce a full summary. Let me now also check what additional content on treatment/management was in that block.Note on your PDF: The file appears to be a scanned (image-based) PDF with no extractable text, so I wasn't able to read its specific content directly. I'll provide a thorough, textbook-level summary of hypertension drawing from Goldman-Cecil Medicine, Guyton & Hall Physiology, and Robbins Pathology.
Hypertension - Comprehensive Summary
Definition
Hypertension is sustained elevation of systemic arterial blood pressure. The standard diagnostic threshold is ≥140 mm Hg systolic and/or ≥90 mm Hg diastolic on office measurement, though ambulatory and home monitoring use lower thresholds (≥135/85 mm Hg). - Goldman-Cecil Medicine, p. 743
Classification
| Category | Systolic (mm Hg) | Diastolic (mm Hg) |
|---|
| Normal | <120 | and <80 |
| Elevated | 120-129 | and <80 |
| Stage 1 HTN | 130-139 | or 80-89 |
| Stage 2 HTN | ≥140 | or ≥90 |
| Hypertensive crisis | ≥180 | and/or ≥120 |
(ACC/AHA 2017 classification; some international guidelines use 140/90 as the Stage 1 threshold)
Types
Primary (Essential) Hypertension (~85-90%)
No single identifiable cause. Results from the interaction of genetic predisposition and environmental factors. The primary vascular abnormality is elevated systemic vascular resistance. - Goldman-Cecil Medicine, p. 743
Secondary Hypertension (~10-15%)
An identifiable, potentially reversible cause. Common causes include:
- Renal artery stenosis
- Primary aldosteronism (Conn syndrome)
- Pheochromocytoma
- Cushing syndrome
- Obstructive sleep apnea
- Chronic kidney disease
- Thyroid/parathyroid disorders
- Medications (NSAIDs, OCPs, sympathomimetics)
Pathophysiology
Key Mechanisms in Primary Hypertension
1. Obesity and Sympathetic Activation
Excess visceral fat triggers sympathetic nervous system overactivity (particularly renal sympathetics), activates the renin-angiotensin-aldosterone system (RAAS), causes insulin resistance, and compresses the renal medulla - all of which impair renal pressure natriuresis. Up to 65-75% of the risk for primary hypertension is attributable to excess adiposity. - Guyton & Hall Physiology, p. 247
2. Sodium Retention
The hallmark mechanism is impaired ability of the kidneys to excrete sodium at normal arterial pressure. This causes fluid retention, increased cardiac output, and then peripheral vasoconstriction - raising BP until sodium balance is eventually achieved at a higher pressure set-point ("resetting of pressure natriuresis"). - Robbins Pathology, p. 464
3. RAAS Activation
Angiotensin II drives vasoconstriction and aldosterone-mediated sodium retention. Local intrarenal RAAS activation is especially important. Ectopic renin synthesis can occur in cyst walls and dilated tubules.
4. Genetic Factors
Over 500 genetic variants are linked to BP levels. Several rare monogenic forms exist:
- Liddle syndrome - gain-of-function ENaC mutation (autosomal dominant)
- Gordon syndrome - overactive NaCl transporter in distal tubule
- Apparent mineralocorticoid excess - 11β-HSD2 deficiency allowing cortisol to activate mineralocorticoid receptor
- Goldman-Cecil Medicine, p. 743
Vascular Pathology
Sustained hypertension causes degenerative changes in blood vessel walls. Three key forms of small-vessel disease occur:
1. Hyaline Arteriolosclerosis
Homogeneous pink hyaline thickening with luminal narrowing. Caused by plasma protein leakage across injured endothelium and increased smooth-muscle matrix synthesis. Common in both hypertension and diabetes.
2. Hyperplastic Arteriolosclerosis ("Onion-Skinning")
Concentric laminated thickening of arteriolar walls, seen in malignant hypertension. Causes severe luminal obliteration.
3. Fibrinoid Necrosis
Acute vascular injury with deposition of fibrin in vessel walls; associated with hypertensive emergencies.
Fig. 11.5 Vascular pathology in hypertension. (A) Hyaline arteriolosclerosis. (B) Hyperplastic arteriolosclerosis (onion-skinning). - Robbins Pathology
Clinical Features
Most hypertensive patients are asymptomatic - hypertension is called the "silent killer." Some may notice:
- Sleep disturbances, fatigue
- Poor exercise tolerance
- Headache (typically occipital, with severe/malignant hypertension)
Physical exam findings (in approximate order of appearance):
- Hypertensive retinopathy (earliest sign)
- Cardiac enlargement (LVH on ECG/CXR)
- Elevated serum creatinine
- Then: stroke, ischemic heart disease, heart failure, CKD
Hypertensive emergency: BP typically ≥180/110 mm Hg + new/worsening end-organ damage (hypertensive encephalopathy, ARDS, AKI, aortic dissection). - Goldman-Cecil Medicine, p. 743
Diagnosis
Three goals on initial evaluation:
- Accurate BP measurement - Confirm with out-of-office readings (home/ambulatory BP monitoring)
- Identify non-BP cardiovascular risk factors - for global CVD risk estimation
- Screen for secondary hypertension in selected patients
Workup:
- Urinalysis, serum creatinine, electrolytes, fasting glucose, lipid panel
- ECG (for LVH)
- Echocardiogram if indicated
- Renal imaging, aldosterone/renin ratio, 24-hr urine catecholamines for secondary causes
Management
Lifestyle Modifications (First-Line for All Stages)
| Intervention | Expected SBP Reduction |
|---|
| Weight loss (10 kg) | 5-20 mm Hg |
| DASH diet | 8-14 mm Hg |
| Sodium restriction (<2.4 g/day) | 2-8 mm Hg |
| Aerobic exercise (30 min, most days) | 4-9 mm Hg |
| Limit alcohol | 2-4 mm Hg |
Dietary sodium restriction - equivalent in effect to a single add-on drug - is especially effective in resistant hypertension. - Goldman-Cecil Medicine, p. 743
Pharmacotherapy
First-line drug classes:
- Thiazide diuretics (e.g., hydrochlorothiazide, chlorthalidone) - reduce volume
- ACE inhibitors / ARBs - block RAAS; preferred in diabetes, CKD, heart failure
- Calcium channel blockers (CCBs) - vasodilators; preferred in isolated systolic HTN and elderly
- Beta-blockers - preferred with ischemic heart disease, heart failure, certain arrhythmias
Special considerations:
- Black patients: CCBs and thiazides preferred (ACE inhibitors less effective as monotherapy)
- CKD with proteinuria: ACE inhibitor or ARB mandatory
- Resistant hypertension: Add spironolactone (mineralocorticoid antagonist) as 4th agent
- Hypertensive emergency: IV agents (labetalol, nicardipine, nitroprusside) - lower BP by no more than 25% in the first hour to avoid ischemia
End-Organ Complications (Target Organ Damage)
| Organ | Complication |
|---|
| Brain | Ischemic/hemorrhagic stroke, hypertensive encephalopathy, vascular dementia |
| Heart | LVH, coronary artery disease, MI, heart failure, atrial fibrillation |
| Kidney | Nephrosclerosis, CKD, ESRD |
| Eyes | Hypertensive retinopathy, retinal artery/vein occlusion |
| Aorta | Aortic dissection, aortic aneurysm |
Secondary Hypertension - Key Clues
| Cause | Clinical Clue |
|---|
| Renal artery stenosis | Abdominal bruit, young woman (FMD) or smoker with PAD |
| Primary aldosteronism | Hypokalemia, low renin, high aldosterone |
| Pheochromocytoma | Episodic headache, diaphoresis, palpitations ("spells") |
| Cushing syndrome | Central obesity, striae, buffalo hump |
| Obstructive sleep apnea | Obesity, snoring, daytime somnolence, morning BP surge |
| Thyroid disease | Check TSH in resistant hypertension |
Sources: Goldman-Cecil Medicine International Edition, 2 Vol. Set | Guyton & Hall Textbook of Medical Physiology | Robbins, Cotran & Kumar Pathologic Basis of Disease
Note on your PDF: The uploaded file was a scanned (image-based) PDF, so its text could not be extracted automatically. The summary above draws on authoritative medical textbooks. If you share what specific topic/area your PDF covers, I can tailor this further.Here is the full summary above. A quick note on the PDF:
Your uploaded file (hypertension.pdf) appears to be a scanned document with no digitally embedded text, so automated extraction was not possible. The comprehensive summary above is built from four authoritative textbook sources:
- Goldman-Cecil Medicine - clinical presentation, diagnosis, and treatment
- Guyton & Hall Physiology - pathophysiological mechanisms
- Robbins Pathology - vascular pathology and histology
- Brenner & Rector's The Kidney - renal mechanisms
The summary covers the full spectrum: definition, classification, pathophysiology (RAAS, sympathetic activation, sodium retention, genetics), vascular histopathology (with the microscopy image), clinical features, diagnosis, lifestyle and drug management, end-organ complications, and secondary hypertension clues.
If you'd like me to go deeper on any particular section - say, antihypertensive drug mechanisms, hypertensive emergencies, or hypertension in specific populations (pregnancy, CKD, elderly) - just let me know.